B

Bio Essence Corp
OTC:BIOE

Watchlist Manager
Bio Essence Corp
OTC:BIOE
Watchlist
Price: 0.055 USD Market Closed
Market Cap: $2.1m

Relative Value

The Relative Value of one BIOE stock under the Base Case scenario is hidden USD. Compared to the current market price of 0.055 USD, Bio Essence Corp is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BIOE Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

BIOE Competitors Multiples
Bio Essence Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Bio Essence Corp
OTC:BIOE
2.1m USD 3.7 -13 -2.6 -2.6
US
GE Vernova LLC
NYSE:GEV
228.5B USD 0 0 0 0
UK
Eight Capital Partners PLC
F:ECS
158.4B EUR 0 0 0 0
US
China Industrial Group Inc
OTC:CIND
121B USD 351.6 4 020.7 3 417.4 3 537.2
NL
Nepi Rockcastle NV
JSE:NRP
97.6B ZAR 5.6 10.4 14.2 14.2
CH
Galderma Group AG
SIX:GALD
35.3B CHF 0 0 0 0
US
CoreWeave Inc
NASDAQ:CRWV
40.8B USD 0 0 0 0
US
Coupang Inc
F:788
30.4B EUR 1 165 29.9 62.7
US
Symbotic Inc
NASDAQ:SYM
30.7B USD 12.8 -2 821.1 -3 701.9 -594.8
ZA
Vukile Property Fund Ltd
JSE:VKE
28.8B ZAR 5.3 6.6 17 17
US
Circle Internet Group Inc
NYSE:CRCL
27.3B USD 0 0 0 0
P/S Multiple
Revenue Growth P/S to Growth
US
B
Bio Essence Corp
OTC:BIOE
Average P/S: 63.3
3.7
N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
14%
N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
351.6
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
5.6
N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
15%
N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Coupang Inc
F:788
1
12%
0.1
US
Symbotic Inc
NASDAQ:SYM
12.8
26%
0.5
ZA
V
Vukile Property Fund Ltd
JSE:VKE
5.3
-24%
N/A
US
C
Circle Internet Group Inc
NYSE:CRCL
Not Available
28%
N/A
P/E Multiple
Earnings Growth PEG
US
B
Bio Essence Corp
OTC:BIOE
Average P/E: 1 050.7
Negative Multiple: -13
N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
19%
N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
4 020.7
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
10.4
N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
44%
N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Coupang Inc
F:788
165
105%
1.6
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -2 821.1 N/A N/A
ZA
V
Vukile Property Fund Ltd
JSE:VKE
6.6
-5%
N/A
US
C
Circle Internet Group Inc
NYSE:CRCL
Not Available N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
B
Bio Essence Corp
OTC:BIOE
Average EV/EBITDA: 869.6
Negative Multiple: -2.6
N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
72%
N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
3 417.4
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
14.2
N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
25%
N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Coupang Inc
F:788
29.9
55%
0.5
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -3 701.9 N/A N/A
ZA
V
Vukile Property Fund Ltd
JSE:VKE
17
12%
1.4
US
C
Circle Internet Group Inc
NYSE:CRCL
Not Available N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
B
Bio Essence Corp
OTC:BIOE
Average EV/EBIT: 907.8
Negative Multiple: -2.6
N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
93%
N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
3 537.2
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
14.2
N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
34%
N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Coupang Inc
F:788
62.7
82%
0.8
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -594.8 N/A N/A
ZA
V
Vukile Property Fund Ltd
JSE:VKE
17
10%
1.7
US
C
Circle Internet Group Inc
NYSE:CRCL
Not Available N/A N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett